HSP90AA1 and chronic obstructive pulmonary disease: Notably, airway goblet cell metaplasia, a pathognomonic feature of COPD-associated pulmonary dysfunction,25 is maintained through HSP90-dependent mechanisms, with preclinical studies demonstrating that pharmacological HSP90 inhibition both reverses established metaplasia and attenuates disease progression.26